Market Research Report
Brazil In Vitro Diagnostics Market - Growth, Trends, and Forecasts (2020 - 2025)
|Published by||Mordor Intelligence LLP||Product code||391030|
|Published||Content info||80 Pages
Delivery time: 2-3 business days
|Brazil In Vitro Diagnostics Market - Growth, Trends, and Forecasts (2020 - 2025)|
|Published: June 1, 2020||Content info: 80 Pages||
Brazil is a country with a growing middle-class population, a stabilizing economy, increasing urban population, and a supportive government. The country is showing a major shift in the private healthcare sector, which is a supporting factor for the IVD market.
The Brazilian healthcare funding is supported by the Ministry of Health, which runs the government hospitals in the country. The rising interests of the Brazilian researchers in molecular testing technologies, prenatal screening, and point of care (POC) glucose testing are the primary factors augmenting the growth of the market studied.
According to the National Institute of Health, the prevalence of diabetes in Brazil was around 6.3% to 13.5% in 2016. This rising prevalence of diabetes in the country is propelling the growth of the in vitro diagnostics in Brazil. Therefore, factors, such as the rising interest of the Brazilian researchers in advanced diagnostics and high prevalence of chronic diseases, are contributing to the growth of the IVD market in the country.
Molecular Diagnostics Segment Spearheaded the Market Studied
Danaher Corporation, Roche Diagnostics, Becton, Dickinson and Company, bioMerieux, and Bio-Rad Laboratories Inc. are some of the major players in the market studied. The major companies are focusing on increasing technological advancements, in order to address customer needs, like fully automated systems, which reduces manual processes and consumables and also provides fast and accurate results.